Publizoom

Pharmanovia Benelux B.V.

Company number 0884.861.912

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won
14
Amount won alone
€3,841,767 excl. VAT
Shared contracts
9 (multi-supplier framework agreements)
Period
12 January 2024 – 16 September 2026

Its main clients

Where and what

Supplies · 14

East Flanders · 3 West Flanders · 2 Hainaut · 2 Limburg · 2 Brussels-Capital · 1 Antwerp · 1 Flemish Brabant · 1

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned endContractCurrent holderAmount
2 June 2027
re-tender around December 2026
Fourniture d'analogues de la somatostatine
MercurHosp ASBL
Pharmanovia Benelux B.V.
NOVARTIS PHARMA
2 bids received
€606,086
27 July 2027
re-tender around January 2027
Raamovereenkomst voor de aankoop en levering van cytostatica en immunosuppressiva
VZW Maria Middelares framework agreement
EG
ACCORD HEALTHCARE
BAXTER BELGIUM
Pharmanovia Benelux B.V.
Fresenius Kabi
Arega Pharma
4 bids received
€28,577,921
1 December 2027
re-tender around June 2027
Fourniture 'd'anastroazole, anagrelide, letrozole, bevacizumab, bortezomib et de fulvestrant 2023-2027
HUmani SC framework agreement
Arega Pharma BV
Celltrion Healthcare Netherlands BV
Eurogenerics
Pharmanovia Benelux B.V.
7 bids received
€832,552
12 December 2027
re-tender around June 2027
Raamovereenkomst voor het leveren van Cytostatica Parenteraal
Hospilim VZW framework agreement
Roche NV
Accord Healthcare BV
Celltrion Healthcare Netherlands BV
Pharmanovia Benelux BV
Viatris BV
Fresenius Kabi NV
Baxter Belgium SRL
Aurobindo NV
AstraZeneca NV
Arega Pharma BV
Servier Benelux NV
MSD Belgium BV
Sandoz NV
4 bids received
€375,000,000
3 June 2028
re-tender around December 2027
Raamovereenkomst voor de aankoop en levering van Somatostatine analogen
VZW Maria Middelares framework agreement
Pharmanovia Benelux B.V.
Ipsen
2 bids received
€2,105,441
26 November 2028
re-tender around May 2028
Raamovereenkomst voor levering van cytostatica - METHOTREXAAT SC
AZ Turnhout vzw
Pharmanovia Benelux BV
2 bids received
€429,316
10 April 2029
re-tender around October 2028
Raamovereenkomst voor de levering van zoledroninezuur
Hospilim VZW framework agreement
Pharmanovia Benelux B.V.
3 bids received
€2,257,734
5 August 2029
re-tender around February 2029
Médicaments antinéoplasiques (ATC L01) et autres immunosuppresseurs (ATC L04AX)
Healthcare Public Procurement (HeCaPP)
Pharmanovia Benelux B.V.
Viatris
ACCORD HEALTHCARE
sandoz
3 bids received
€661,259
8 August 2029
re-tender around February 2029
Raamovereenkomst voor het leveren van methotrexaat SC
AZ Oudenaarde framework agreement
Pharmanovia Benelux B.V.
2 bids received
€400,000

Contracts won

DateContractBuyerAmount
16/09/2026 Methotrexaat VITAZ vzw €754,717
17/06/2026 Raamovereenkomst voor de aankoop en levering van Somatostatine analogen VZW Maria Middelares €2,105,441
shared by 2
08/05/2026 Raamovereenkomst voor de aankoop en levering van cytostatica en immunosuppressiva VZW Maria Middelares €28,577,921
shared by 6
07/04/2026 Parenterale cytostatica AZ Delta vzw €3,950,688
shared by 12
05/03/2026 Fourniture d’acide zolédronique, concentré de complexe prothrombinique et fibrinogène HUmani SC €954,778
shared by 2
01/10/2025 Fourniture d'analogues de la somatostatine MercurHosp ASBL €606,086
shared by 2
18/08/2025 Raamovereenkomst voor het leveren van methotrexaat SC AZ Oudenaarde €400,000
08/08/2025 Médicaments antinéoplasiques (ATC L01) et autres immunosuppresseurs (ATC L04AX) Healthcare Public Procurement (HeCaPP) €661,259
shared by 4
29/04/2025 Raamovereenkomst voor de levering van zoledroninezuur Hospilim VZW €2,257,734
29/11/2024 Raamovereenkomst voor levering van cytostatica - METHOTREXAAT SC AZ Turnhout vzw €429,316
18/11/2024 Zoledroninezuur UZ Leuven €1,400,107
shared by 2
09/04/2024 Fourniture de Bortezomib MercurHosp ASBL –
26/01/2024 Raamovereenkomst voor het leveren van Cytostatica Parenteraal Hospilim VZW €375,000,000
shared by 13
12/01/2024 Fourniture 'd'anastroazole, anagrelide, letrozole, bevacizumab, bortezomib et de fulvestrant 2023-2027 HUmani SC €832,552
shared by 4

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.